Stay updated with breaking news from Jacobs Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Intact Investment Management Inc. cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 55.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 93,500 shares of the biopharmaceutical company’s stock after selling 117,400 shares during the quarter. Intact Investment […]
First Republic Investment Management Inc. cut its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 2.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 238,095 shares of the biopharmaceutical company’s stock after selling 6,661 shares during the quarter. […]
Quantinno Capital Management LP raised its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 60.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 27,361 shares of the biopharmaceutical company’s stock after purchasing an additional 10,330 shares […]
Shelton Capital Management reduced its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) by 82.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,600 shares of the biopharmaceutical company’s stock after selling 102,683 shares during the quarter. Shelton Capital Management’s holdings […]
Sonoma Private Wealth LLC acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Get Rating) in the 4th quarter, according to the company in its most recent filing with the SEC. The firm acquired 2,905 shares of the biopharmaceutical company’s stock, valued at approximately $249,000. Several other institutional investors and hedge funds have also […]